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Increased Vulnerability of Brain Mitochondria in
Diabetic (Goto-Kakizaki) Rats With Aging and
Amyloid- Exposure
Paula I. Moreira,1 Maria S. Santos,1 Anto´nio M. Moreno,1 Raquel Seic¸a,2 and Catarina R. Oliveira2
This study evaluated the respiratory indexes (respira-
tory control ratio [RCR] and ADP/O ratio), mitochon-
drial transmembrane potential (m), repolarization
lag phase, repolarization level, ATP/ADP ratio, and
induction of the permeability transition pore of brain
mitochondria isolated from normal Wistar and GK dia-
betic rats of different ages (1.5, 12, and 24 months of
age). The effect of amyloid -peptides, 50 mol/l A25–35
or 2 mol/l A1–40, on mitochondrial function was also
analyzed. Aging of diabetic mice induced a decrease in
brain mitochondrial RCR, ADP/O, and ATP/ADP ratios
but induced an increase in the repolarization lag phase.
Brain mitochondria from older diabetic rats were more
prone to the induction of the permeability transition
pore, i.e., mitochondria from 24-month-old diabetic rats
accumulated much less Ca2 (20 mol/l) than those
isolated from 12-month-old rats (50 mol/l) or 1.5-
month-old rats (100 mol/l). In the presence of 50
mol/l A25–35 or 2 mol/l A1–40, age-related mitochon-
drial effects were potentiated. These results indicate
that diabetes-related mitochondrial dysfunction is ex-
acerbated by aging and/or by the presence of neurotoxic
agents such as amyloid -peptides, supporting the idea
that diabetes and aging are risk factors for the neuro-
degeneration induced by these peptides. Diabetes 52:
1449–1456, 2003
Type 2 diabetes accounts for 90% of the existingcases of diabetes and is characterized by defectsin both insulin action and secretion (1). Manystudies demonstrated that diabetes produces
molecular, cellular, morphological, and behavioral
changes in the central nervous system (CNS) (2).
Pardridge et al (3) showed the existence of insulin recep-
tors in the endothelium of the human blood-brain barrier,
allowing receptor-mediated active transport of insulin into
the brain. Insulin-sensitive glucose transporters are found
not only at the blood-brain barrier but also in glia express-
ing partially insulin-sensitive GLUT1 (4,5) and in some
neurons expressing GLUT1 (4) and/or GLUT4 (6,7). Re-
cently, Bingham et al. (8) showed that insulin has a
significant effect on global brain glucose metabolism,
mainly in the cerebral cortex. The authors suggest that this
effect may be either a direct effect of insulin, stimulating
glucose uptake and metabolism, or an indirect effect
achieved via insulin-stimulated neuronal activation with
secondary increment in cell glucose metabolism. These
results raise the hypothesis that insulin can access the
insulin receptors in the brain and have a metabolic effect
in this organ, which may be maximal at basal circulating
insulin concentrations.
Diabetes is often associated with mitochondrial dis-
eases characterized by defects in the mitochondrial ge-
nome (9). Mitochondria play a central role in the
development of type 2 diabetes by regulating energy
balance and the generation of reactive oxygen species
(10). In Alzheimer’s disease (AD), a major imbalance
between glucose and oxygen consumption has been found
in the incipient stage, whereas in the advanced stage, both
glucose and oxygen consumption are diminished (11).
This could be a consequence of deviant insulin action or
brain insulin receptor function, which can affect brain
energy metabolism (11). These abnormalities in insulin
metabolism may account for the pathological changes
(formation of senile plaques and neurofibrillary tangles)
found in AD (12,13). Several lines of evidence suggest that
amyloid deposition in the brain contributes to neuronal
degeneration in AD (14) just as amyloid formation in the
pancreas is believed to contribute to -cell loss in type 2
diabetes (15). Hoyer (16) argued that in late-onset AD, a
disturbance in the control of neuronal glucose metabolism
consequent to impaired insulin signaling strongly resem-
bles the pathophysiology of type 2 diabetes in nonneural
tissue. Two recent prospective studies have established
that diabetes increases the risk of dementia in general and
AD in particular (17,18).
Several animal models are available for experimental
investigation on type 2 diabetes. One of those models is
the Goto-Kakizaki (GK) rat: a nonobese, spontaneously
diabetic animal (19) produced by selective breeding of
Wistar rats and first characterized by Goto and Kakizaki
(20).
The aim of this work was to analyze the impact of aging
and/or the presence of amyloid -peptides (A) on the
function of brain mitochondria isolated from diabetic GK
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rats. For this purpose, the following parameters were
examined: mitochondrial respiration, mitochondrial trans-
membrane potential, levels of ATP, and the induction of
the permeability transition pore. Studies on aging in an
animal model of type 2 diabetes may identify a key
metabolic feature common to that disorder and late-onset
AD. One such feature could be a mitochondria-associated
oxidative stress in AD brain (21,22) and in the brain of GK
rats, as demonstrated previously in our laboratory (23).
RESEARCH DESIGN AND METHODS
Materials. A25–35 and A1–40 were obtained from Bachem AG (Bubendorf,
Germany). Protease (Subtilisin Carlsberg) type VIII was obtained from Sigma
(Sintra, Portugal). Digitonin was obtained from Calbiochem. All the other
chemicals were of the highest grade of purity commercially available.
Animals. Male GK and control Wistar rats that were 1.5, 12, and 24 months of
age were housed in our animal colony (Laboratory Research Center, Univer-
sity Hospital, Coimbra, Portugal). They were maintained under controlled
light and humidity with free access to water and powdered rodent diet (diet
C.R.F. 20, Charles River, L’Arbresle, France). Glucose tolerance tests were
used to select GK rats for study. Adhering to procedures approved by the
Institutional Animal Care and Use Committee, the animals were killed by
cervical displacement and decapitation.
Determination of blood glucose and glycated hemoglobin (HbA1c, GHb)
levels. Immediately after the animals were killed, blood glucose was deter-
mined by a glucose oxidase reaction, using a glucometer and compatible
reactive tests. GHb and HbA1c levels were determined through ionic change
chromatographic assay. GHb is a common term for posttranslationally mod-
ified molecules of HbA, resulting from a nonenzymatic binding of glucose
(glycation) to the amino acid residues in - and/or -globin chains. Approxi-
mately 80% of GHb is HbA1c, which is hemoglobin irreversibly glycated at one
or both NH2-terminal valine amino acid of each -chain.
Isolation of brain mitochondria. Brain mitochondria were isolated from
male Wistar and GK rats by the method of Rosenthal et al. (24), with slight
modifications, using 0.02% digitonin to free mitochondria from the synapto-
somal fraction. In brief, a rat was decapitated, and the whole brain minus the
cerebellum was rapidly removed, washed, minced, and homogenized at 4°C in
10 ml of isolation medium (225 mmol/l mannitol, 75 mmol/l sucrose, 5 mmol/l
HEPES, 1 mmol/l EGTA, 1 mg/ml BSA [pH 7.4]) containing 5 mg of the
bacterial protease. Single brain homogenates were brought to 30 ml and then
centrifuged at 2,000g for 3 min. The pellet, including the fluffy synaptosomal
layer, was resuspended in 10 ml of the isolation medium containing 0.02%
digitonin and centrifuged at 12,000g for 8 min. The brown mitochondrial pellet
without the synaptosomal layer was then resuspended again in 10 ml of
medium and recentrifuged at 12,000g for 10 min. The mitochondrial pellet was
resuspended in 300 l of resuspension medium (225 mmol/l mannitol, 75
mmol/l sucrose, 5 mmol/l HEPES [pH 7.4]). Mitochondrial protein was
determined by the biuret method calibrated with BSA (25).
Membrane potential measurements. The mitochondrial transmembrane
potential (m) was monitored by evaluating the transmembrane distribution
of tetraphenylphosphonium (TPP) with a TPP-selective electrode prepared
according to Kamo et al. (26) using an Ag/AgCl2 electrode as reference.
Reactions were carried out in a chamber with magnetic stirring in 1 ml of
reaction medium (100 mmol/l sucrose, 100 mmol/l KCl, 2 mmol/l KH2PO4, 5
mmol/l HEPES, 10 mol/l EGTA [pH 7.4]) supplemented with 3 mol/l TPP.
The experiments were started by adding 5 mmol/l succinate to mitochondria
in suspension at 0.8 mg protein/ml. After a steady-state distribution of TPP
had been reached (ca. 2 min of recording), Ca2 was added and m was
recorded. m was estimated from the decrease of TPP concentration in the
reaction medium as described elsewhere (27). Homogenates were incubated
with 50 mol/l A25–35 or 2 mol/l A1–40 for 5 min before succinate addition.
Mitochondrial respiration. Oxygen consumption of isolated mitochondria
was monitored polarographically with a Clark oxygen electrode (28) con-
nected to a suitable recorder in a 1-ml, thermostated, water-jacketed closed
chamber, with magnetic stirring. The reactions were carried out at 30°C in 1
ml of the reaction medium with 0.8 mg of protein. Homogenates were
incubated with 50 mol/l A25–35 or 2 mol/l A1–40 for 5 min before succinate
addition.
Analysis of ATP. At the end of the m experiments, each mitochondrial
suspension was rapidly centrifuged at 14,000 rpm for 6 min with 0.3 mol/l
perchloric acid. The supernatants were neutralized with 10 mol/l KOH in 5
mol/l Tris and centrifuged at 14,000 rpm for 5 min. The resulting supernatants
were assayed for ATP by separation in a reverse-phase high-performance
liquid chromatography. The chromatography apparatus was a Beckman-
System Gold, consisting of a 126 Binary Pump Model and 166 Variable UV
detector controlled by a computer. The detection wavelength was 254 nm, and
the column was a Lichrosphere 100 RP-18 (5 m) from Merck. An isocratic
elution with 100 mmol/l phosphate buffer (KH2PO4; pH 6.5) and 1.0% methanol
was performed with a flow rate of 1 ml/min. The required time for each
analysis was 6 min.
Statistical analysis. Results are presented as mean  SE of the indicated
number of experiments. Statistical significance was determined using the
one-way ANOVA test for multiple comparisons, followed by the post hoc
Tukey-Kramer test. P 	 0.05 was considered significant.
RESULTS
Glycemia and HbA1c levels in Wistar control and GK
rats. For confirming diabetes in GK rats, glycemia and the
glycated hemoglobin (HbA1c, GHb) levels were deter-
mined (Table 1). The percentage of hemoglobin in gly-
cated form (GHb and HbA1C) was significantly higher in
GK than in Wistar control rats (Table 1). Similarly, blood
glucose levels increased in GK rats when compared with
Wistar control rats. However, the glycemia of 12-month-
old GK rats was higher than that of 24-month-old rats.
Effect of aging and A on brain mitochondrial respi-
ration. Respiratory control ratio (RCR) is the ratio be-
tween mitochondrial respiration states 3 (consumption of
oxygen in the presence of substrate and ADP) and 4
(consumption of oxygen after ADP has been consumed).
RCR decreased with aging (Fig. 1A). The ADP/O ratio also
showed a significant decrease with age (Fig. 2A). The
ADP/O ratio, an indicator of oxidative phosphorylation
efficiency, is expressed by the ratio between the amount of
ADP added and the oxygen consumed during state 3
respiration. In the presence of 50 mol/l A25–35 or 2
mol/l A1–40, the effects of age on both respiratory
indexes were exacerbated: the decreases on RCR (Fig. 1A)
and ADP/O ratio (Fig. 2A) were potentiated. A similar
pattern occurred in Wistar control rats (Fig. 1B and 2B).
TABLE 1
Characterization of Wistar control and GK rats
Wistar control
(1.5 months;
n 
 8)
GK (1.5
months;
n 
 8)
Wistar control
(12 months;
n 
 7)
GK (12
months;
n 
 7)
Wistar control
(24 months;
n 
 5)
GK (24
months;
n 
 5)
Glycemia (mg/ml) 111.4 9.9 223.6 27.1c 102.0 4.2e 256.8 13.5a,g 85.5 6.5e,i 180.5 44.1
HbA1C (%) 6.3 0.7 6.0 0.3 5.2  0.1 9.6  0.5
a,d,g 5.2  0.4f,h,i 7.7 0.3b,e,h,j,k
GHb (%) 7.2 0.9 6.6 0.5 6.1  0.1 12.6 0.8a,d,g 5.9  0.6i 9.8 0.4b,e,h,j,k
Data are the means  SE. HbA1c and GHb data are expressed as a percentage of the total hemoglobin.
aP 	 0.001; bP 	 0.01; cP 	 0.05, when
compared with mitochondria isolated from 1.5-month-old Wistar control rats. dP 	 0.001, eP 	 0.01; fP 	 0.05, when compared with
mitochondria isolated from 1.5-month-old GK rats. gP 	 0.001; hP 	 0.01, when compared with mitochondria isolated from 12-month-old
Wistar control rats. iP 	 0.001; jP 	 0.05; when compared with mitochondria isolated from 12-month-old GK rats. kP 	 0.01, when compared
with mitochondria isolated from 24-month-old Wistar control rats.
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However, the effects of aging and A peptides were less
pronounced than those observed in 12- and 24-month-old
GK rats.
Effect of aging and A on m, repolarization lag
phase, repolarization level, and ATP/ADP ratio. The
mitochondrial m is fundamental for the phenomenon
of oxidative phosphorylation, the conversion of ADP to
ATP via ATP synthase. Mitochondrial respiratory chain
pumps H out of the mitochondrial matrix across the
inner mitochondrial membrane. The H gradient estab-
lishes an electrochemical potential (p) resulting in a pH
(pH) and a voltage gradient (m) across the mitochon-
drial inner membrane. Figure 3 is a representative trace of
the effect of A25–35 on m (decreased), lag phase
(increased), and repolarization phase (decreased) of mito-
chondria isolated from 1.5-month-old diabetic rats. As
shown in Table 2, age did not affect substantially the m.
However, the presence of 50 mol/l A25–35 or 2 mol/l
A1–40 led to a significant decrease of m in mitochon-
dria isolated from 24-month-old rats (Table 2).
Similarly, aging did not affect either repolarization lag
phase (corresponding to ADP phosphorylation) or repo-
larization level (time necessary for mitochondria to rees-
tablish the m, after ADP phosphorylation) of diabetic
brain mitochondria (Table 2). However, the presence of 50
mol/l A25–35 or 2 mol/l A1–40 led to a significant
decrease of both parameters. In the presence of 2 mol/l
A1–40, those parameters could not be evaluated in mito-
chondria isolated from 24-month-old rats because after
depolarization induced by ADP, the basal m could not
be reestablished as a result of the inability of mitochondria
to phosphorylate all of the ADP added, in the presence of
the peptide.
FIG. 1. Effect of age and A peptides on RCR of brain mitochondria
isolated from GK (A) and Wistar control (B) rats. Freshly isolated
brain mitochondria (0.8 mg) in 1 ml of the standard medium supple-
mented with 2 mol/l rotenone were energized with 5 mmol/l succinate.
Isolates were preincubated with 50 mol/l A25–35 and 2 mol/l A1–40
for 5 min at 30°C before mitochondria energization. aP < 0.001; bP <
0.01, when compared with mitochondria isolated from 1.5-month-old
GK rats. eP < 0.01, when compared with mitochondria isolated from
1.5-month-old GK rats, in the presence of 2 mol/l A1–40.
gP < 0.001;
hP < 0.01, when compared with mitochondria isolated from 12-month-
old GK rats. kP < 0.05, when compared with mitochondria isolated from
12-month-old GK rats, in the presence of 50 mol/l A25–35.
lP < 0.001,
when compared with mitochondria isolated from 24-month-old GK rats.
nP < 0.001, when compared with mitochondria isolated from 1.5-month-
old Wistar control rats. rP < 0.05, when compared with mitochondria
isolated from 1.5-month-old Wistar control rats, in the presence of 50
mol/l A25–35.
sP < 0.001, when compared with mitochondria isolated
from 1.5-month-old Wistar control rats, in the presence of 2 mol/l
A1–40.
uP < 0.001; vP < 0.05, when compared with mitochondria
isolated from 12-month-old Wistar control rats. wP < 0.05, when
compared with mitochondria isolated from 12-month-old Wistar con-
trol rats, in the presence of 50 mol/l A25–35.
xP < 0.001, when
compared with mitochondria isolated from 24-month-old Wistar con-
trol rats.
FIG. 2. Effect of aging and A peptides on ADP/O ratio of brain
mitochondria isolated from GK (A) and Wistar control (B) rats. Freshly
isolated brain mitochondria (0.8 mg) in 1 ml of the standard medium
supplemented with 2 mol/l rotenone were energized with 5 mmol/l
succinate. Isolates were preincubated with 50 mol/l A25–35 and 2
mol/l A1–40 for 5 min at 30°C before mitochondria energization.
aP <
0.001, when compared with mitochondria isolated from 1.5-month-old
GK rats. cP < 0.001; dP < 0.01, when compared with mitochondria
isolated from 1.5-month-old GK rats, in the presence of A25–35.
eP <
0.01; fP < 0.05, when compared with mitochondria isolated from
1.5-month-old GK rats, in the presence of A1–40.
gP < 0.001; iP < 0.05,
when compared with mitochondria isolated from 12-month-old GK rats.
nP < 0.001; oP < 0.01; pP < 0.05, when compared with mitochondria
isolated from 1.5-month-old Wistar control rats. qP < 0.01, when
compared with mitochondria isolated from 1.5-month-old Wistar con-
trol rats, in the presence of A25–35.
tP < 0.01, when compared with
mitochondria isolated from 1.5-month-old Wistar control rats, in the
presence of A1–40.
vP < 0.05, when compared with mitochondria
isolated from 12-month-old Wistar control rats. yP < 0.01, when com-
pared with mitochondria isolated from 24-month-old Wistar control
rats.
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As shown in Fig. 4A, an age-related decrease in ATP/
ADP ratio of diabetic brain mitochondria was observed.
The presence of 50 mol/l A25–35 or 2 mol/l A1–40
exacerbated the decrease on ATP levels, this effect being
more pronounced in the presence of 2 mol/l A1–40. A
similar pattern occurred with Wistar control rats (Fig. 4B).
However, the effects of aging and A were less pro-
nounced than those observed in 12- and 24-month-old GK
rats.
Effect of aging and A on the induction of mitochon-
drial permeability transition pore. The drop of m is
a typical phenomenon that leads to the induction of
permeability transition pore (PTP). Figures 5 and 6 show
the alteration of brain mitochondrial electric potential
(m) induced by age and A25–35, respectively.
In mitochondria isolated from 1.5-month-old GK rats,
after energizing with succinate, the first pulse of 50 mol/l
Ca2 led to a rapid depolarization followed by a partial
repolarization. However, a second pulse of Ca2 led to an
irreversible depolarization (Fig. 5A).
Mitochondria isolated from 12- and 24-month-old GK
rats showed a smaller capacity to accumulate Ca2. They
undergo PTP induction after two pulses of 25 mol/l Ca2
or 10 mol/l Ca2, respectively (Fig. 5B and 5C). The
collapse of m was prevented by adding EGTA or
oligomycin plus ADP, which completely restored m to
the state 4 level (e.g., before Ca2 addition) (Fig. 5B). In
mitochondria isolated from 24-month-old rats, A25–35 (50
mol/l; Fig. 6) induced a significant decrease of m
measured after mitochondria energization. These mito-
chondria were more susceptible to the amount of Ca2
added, because they undergo PTP in the presence of lower
Ca2 concentrations. The higher susceptibility to Ca2
addition induced by A25–35 also occurred in mitochondria
isolated from 1.5- and 12-month-old GK rats (data not
shown). The presence of 0.85 mol/l cyclosporin A (CsA;
specific inhibitor of PTP) added 2 min before Ca2 af-
forded a clear protection of mitochondria because it
prevents the depolarization induced by Ca2 (Fig. 7A).
In addition, the preincubation (2 min) of mitochondria
with 1 mmol/l ADP plus 2 g/ml oligomycin completely
prevented mitochondria depolarization by increasing dra-
matically the repolarization capacity of mitochondrial mem-
brane after Ca2 accumulation (Fig. 7B).
DISCUSSION
The effect of A on the function of brain mitochondria was
analyzed in GK rats at different ages (1.5, 12, and 24
months). We observed that aging renders diabetic brain
mitochondria more susceptible to toxic insults such as the
neurotoxic A.
The characterization of diabetes in GK rats was per-
formed by determining the blood levels of glucose and
glycated hemoglobin (HbA1C and GHb). A significant in-
crease in GHb and also in glycemia was observed (Table
1). We should note the decrease, although not significant,
in glycemia of 24-month-old GK rats, which is associated
with weight loss, i.e., 24-month-old GK rats presented a
loss in body weight, which may be responsible for glyce-
mia decrement. Besides the genetic predisposition, obesity
is the most important risk factor for the development of
type 2 diabetes. Data from the literature indicate that
weight loss can result in a significant improvement in
blood glucose levels (29).
The isolation procedure used in this study does not
allow separation of mitochondria from different cell types.
Consequently, the observed alterations in mitochondrial
function may derive from changes in one or more cell
types. They include the three types of insulin-sensitive
cells in the brain: vascular epithelial cells, astrocytes, and
some neurons. All three of these cell types are affected in
diabetes. Of great interest here, however, are astrocytes
and neurons, because mitochondria in these cell types are
known to suffer morphological changes in diabetic rats
(30,31). Astrocytes, which are intimately involved in neu-
ronal function, play an important role in brain glucose
metabolism (32) and thus merit as much attention as
neurons in subsequent studies of brain mitochondrial
changes in GK rats.
Hyperglycemia in GK rats could cause brain mitochon-
drial impairment via oxidative stress compromising brain
function. Data from the literature show that hyperglyce-
mia induces oxidative damage in rat brain (23,33). It was
also shown that lipid peroxidation products are increased
in the brain of type 2 diabetic mice, whereas the activity of
antioxidant enzymes, such as catalase and superoxide
dismutase, is decreased (34,35). The presence of lipid
peroxidation products, such as 4-hydroxynonenal (HNE),
reduces the activity of a variety of enzymes that are critical
to normal function of neurons, including glucose trans-
porters (36). HNE has been demonstrated to have the
FIG. 3. Representative trace of the effect of A25–35 on m, repolar-
ization lag phase, and repolarization level of mitochondria isolated
from 24-month-old GK rats. Freshly isolated brain mitochondria (0.8
mg) in 1 ml of the standard medium supplemented with 3 mol/l TPP
and 2 mol/l rotenone were energized with 5 mmol/l succinate. Isolates
were preincubated with 50 mol/l A25–35 for 5 min at 30°C before
mitochondria energization.
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capacity to impair mitochondrial function in brain synap-
tosomes (36). The specific mitochondrial enzymes -keto-
glutarate dehydrogenase and pyruvate dehydrogenase
have been shown to be targets for HNE protein conjuga-
tion, resulting in a decrease of the activity of both enzymes
(37).
Dysfunction of the mitochondrial respiratory chain has
been described in diabetes (38). Accordingly, our data
show an age-related impairment of the respiratory chain
(decrease of RCR; Fig. 1A) and an uncoupling of oxidative
phosphorylation (OXPHOS; decrease of ADP/O ratio; Fig.
2A) in brain mitochondria isolated from GK rats. Inhibition
of cellular energy production has been shown to reduce or
abolish both insulin secretion and action (39). In addition,
the decrement in OXPHOS efficiency is related to a loss in
the control of glucose homeostasis as evidenced by the
increase in tissue and blood lactate levels, as well as by the
change in glucose tolerance (Table 1). The impairment of
FIG. 4. Effect of age and A peptides on ATP/ADP ratio of brain
mitochondria isolated from GK (A) and Wistar control (B) rats. At the
end of incubations such as those described in Figs. 1, 2, and 3,
mitochondrial suspensions were centrifuged and processed for ATP
levels analysis as described in RESEARCH DESIGN AND METHODS. Isolates
were preincubated with 50 mol/l A25–35 and 2 mol/l A1–40 for 5 min
at 30°C before mitochondria energization. aP < 0.001; bP < 0.05, when
compared with mitochondria isolated from 1.5-month-old GK rats; cP <
0.01, dP < 0.05, when compared with mitochondria isolated from rats
1.5-month-old GK rats, in the presence of A25–35;
eP < 0.01, when
compared with mitochondria isolated from rats 1.5-month-old GK rats,
in the presence of A1–40;
fP < 0.05, when compared with mitochondria
isolated from rats 12-month-old GK rats. gP < 0.001; hP < 0.01, when
compared with mitochondria isolated from 1.5-month-old Wistar con-
trol rats; iP < 0.001; jP < 0.01, when compared with mitochondria
isolated from 1.5-month-old Wistar control rats, in the presence of
A25–35;
kP < 0.001, when compared with mitochondria isolated from
1.5-month-old GK rats, in the presence of A1–40;
lP < 0.001; mP < 0.01,
when compared with mitochondria isolated from 24-month-old Wistar
control rats.
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the respiratory chain (Fig. 1A) and the uncoupling of
OXPHOS (Fig. 2A) are not accompanied by a decrease in
m (Table 2). However, an age-related decrease in
ATP/ADP ratio of mitochondria isolated from diabetic rats
occurred (Fig. 4A). Cybrid cells constructed from individ-
uals with maternally inherited diabetes exhibited lactic
acidosis, poor respiration, and marked defects in mito-
chondrial morphology and respiratory chain complex I
and IV activities (40). Because CNS depends so heavily on
ATP production, the inhibition of OXPHOS will affect this
system before any other system. For example, CNS re-
quires a large amount of ATP for the transmission of
impulses along the neural pathway; thus, mitochondrial
function impairment will result in neurodegeneration and
loss in neuronal metabolic control (41,42).
Bioenergetic complications induced by diabetes are
exacerbated by aging. Our data show a more pronounced
mitochondrial dysfunction in older GK rats (12 and 24
months old) (Figs. 1A, 2A, and 4A) when compared with
Wistar control rats of the same age (Figs. 1B, 2B, and 4B).
This indicates that aging is a risk factor for diabetes
increasing the susceptibility to neurotoxic agents. Diabe-
tes leads to functional and structural changes in the brain
that seem to be most pronounced in the elderly. Increased
age is associated with insulin resistance (43). Increasing
data support the idea that mitochondrial function declines
with aging and in age-related diseases such as diabetes and
AD (41,42). Brain mitochondria of GK rats presented an
age-related susceptibility to Ca2, indicating that aging
predisposes diabetic rat mitochondria to the opening of
the PTP (Fig. 5). PTP induction is a well-characterized
process that results in a nonselective increase in the
permeability of the inner mitochondrial membrane to
solutes smaller than 1.5 kDa. Criterial attributes of the PTP
include the dependence on matrix Ca2 concentration and
inhibition by the immunosuppressant CsA (44).
The maintenance of calcium homeostasis represents a
major expenditure within neurons and, through respira-
tory control mechanisms, is tightly coupled to the rates of
OXPHOS and the generation of reactive oxygen species.
Recently, we demonstrated that A and/or Ca2 induce
PTP opening of brain mitochondria (45,46). However, the
opening of PTP may be avoided in the presence of CsA
(specific inhibitor of PTP) and ADP plus oligomycin (Fig.
7), as previously described (47–49).
Another interesting feature is the effect of A on brain
bioenergetics of GK rats. Our results indicate that amyloid
-peptides exacerbate the effects of age-related diabetes.
They potentiate respiratory chain impairment (Fig. 1),
uncoupling of OXPHOS (Fig. 2), a decrease in ATP levels
(Fig. 4), and the susceptibility to PTP opening (Fig. 6).
Several comparisons can be made between the chronic
effects of diabetes and the neurological impairments ob-
served in AD. In patients with AD, an increase in cognitive
FIG. 5. Effect of age on PTP induction: susceptibility to
Ca2 addition. Freshly isolated brain mitochondria (0.8
mg) in 1 ml of the standard medium supplemented with 3
mol/l TPP and 2 mol/l rotenone were energized with
5 mmol/l succinate. A: Mitochondria isolated from 1.5-
month-old GK rats. B: Mitochondria isolated from 12-
month-old GK rats. C: Mitochondria isolated from 24-
month-old GK rats. Ca2 was added 1.5 min after
mitochondria energization. The traces are typical of
three experiments.
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function in response to glucose administration and insulin
therapy has been demonstrated (50), presumably as a
result of an increase in hippocampal glucose utilization.
Neuronal glucose transport and utilization have been
shown to be reduced in AD (51). In streptozotocin-treated
rats, a model of type 1 diabetes, -amyloid toxicity is
potentiated in the hippocampus (52). Furthermore, diabe-
tes and AD have been shown to be associated with
mitochondrial dysfunction. Both diseases occur with im-
paired glucose utilization and deficits in mitochondrial
activity, and metabolic dysfunction is an important com-
ponent in both diseases (38,41). The similarities between
AD and the neurological consequences of diabetes raised
the hypothesis that the life-long effects of hyperglycemia
may predispose patients with diabetes to AD (53). In AD,
the desensitization of the neuronal insulin receptor similar
to what occurs in type 2 diabetes may be of pivotal
significance. This abnormality, along with a reduction in
brain insulin concentration, is assumed to induce several
disturbances, including changes in cellular glucose, ace-
tylcholine, cholesterol, and ATP, which are associated
with abnormalities in cellular homeostasis and with the
formation of both amyloidogenic derivatives and hyper-
phosphorylated tau protein (13).
Our results are consistent with the view that diabetes-
related mitochondrial dysfunction is exacerbated by aging
and/or by the presence of neurotoxic agents, such as A,
suggesting that diabetes and aging are risk factors for the
neurodegeneration induced by these peptides. This study
supports the idea, previously suggested by others (13,16),
that a strong correlation exists between both age-related
pathologies, diabetes and AD, mitochondria being a fun-
damental link in this process.
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